Guangdong Zhongsheng Pharmaceutical (002317.SZ): The innovative drug Arlaidevir project has received top-line analysis data results from two Phase III clinical trials.

16:27 08/02/2026

Zhongsheng Pharmaceuticals (002317.SZ) announced that its controlling subsidiary, Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd. (referred to as "Zhongsheng Ruichuang"), independently developed an innovative drug called Angladavir granules for the treatment of type A influenza in children aged 2 to 11 in Phase III clinical trials (referred to as "Angladavir granules pediatric Phase III clinical trial") and Angladavir tablets for the treatment of type A influenza in adolescents aged 12 to 17 in Phase III clinical trials (referred to as "Angladavir tablets adolescent Phase III clinical trial"). Recently, the top-line analysis data has been obtained.

Guangdong Zhongsheng Pharmaceutical (002317.SZ) announced that its holding subsidiary Guangdong Zhongsheng Ruichuang Biotechnology Co., Ltd. (referred to as "Zhongsheng Ruichuang") has obtained top-line analysis data for the Phase III clinical trials of a class of innovative drugs developed independently by the company, including Angladavir granules for the treatment of children aged 2 to 11 with uncomplicated influenza A and Angladavir tablets for the treatment of adolescents aged 12 to 17 with uncomplicated influenza A. Preliminary results show that Angladavir granules and tablets demonstrate positive therapeutic effects and good safety in the respective age groups, with the trial results meeting the expected objectives.

Ningbo Shanshan (600884.SH) may see a change in its controlling shareholder to Wanwei Group.

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.

Ningbo Shanshan (600884.SH) may see a change in its controlling shareholder to Wanwei Group.

Broad strategy: A-shares may usher in a new round of upward cycle in the future.

Zhejiang Tenchen Controls' subsidiary has become a supplier of passenger car seats for a domestic automotive company in China.